Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881295 · ClinicalTrials.gov registry record · NA
Bioavailability of Potassium From Potatoes and Potassium Gluconate
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01881295: Completed NA study, sponsored by Purdue University.
NCT01881295 is a NA study that has completed, run by Purdue University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01881295, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is designed to compare the effect of sources of potassium on uptake and the effect of potassium on blood pressure.
Primary Outcome
After 4 days of acclimation to the supplementation, absorption of potassium will be measured.
Interventions
- DIETARY_SUPPLEMENT Placebo control
- DIETARY_SUPPLEMENT Low dose potassium gluconate
- DIETARY_SUPPLEMENT Medium dose potassium gluconate
- DIETARY_SUPPLEMENT High dose potassium gluconate
- DIETARY_SUPPLEMENT Low dose potato
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-03-01 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01881295 record still lists
NCT01881295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo control is the first listed.
NCT01881295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01881295 about?
NCT01881295 is a clinical study titled "Bioavailability of Potassium From Potatoes and Potassium Gluconate". This study is designed to compare the effect of sources of potassium on uptake and the effect of potassium on blood pressure.
What is the current status of trial NCT01881295?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2013-03-01. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01881295?
The interventions under investigation include: Placebo control (DIETARY_SUPPLEMENT), Low dose potassium gluconate (DIETARY_SUPPLEMENT), Medium dose potassium gluconate (DIETARY_SUPPLEMENT), High dose potassium gluconate (DIETARY_SUPPLEMENT), Low dose potato (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01881295?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01881295's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI